KRAS and colorectal carcinoma: Among the 150 patients with stage III or lower stage CRC that underwent radical resection, recurrence occurred in 21 patients (14.0%), including 12 of the 45 patients with detectable KRAS mutations in ctDNA (26.7%) and 9 of the 105 patients without such mutations (8.6%).